알렉터 (ALEC)

전일 마감가:

$5.34

열려 있는:

$5.46

하루 거래량:

300.61K

시가총액:

$519.51M

수익:

$97.06M

순이익/손실:

$-130.39M

주가수익비율:

-3.1337

EPS:

-1.72

순현금흐름:

$-186.54M

1주 성능:

+2.67%

1개월 성능:

-8.49%

6개월 성능:

-8.33%

1년 성능:

-17.84%

1일 변동 폭

$5.325

$5.68

52주 변동 폭

$3.66

$9.065

알렉터 Stock (ALEC) Company Profile

명칭

Alector Inc

부문

Healthcare (1213)

산업

Biotechnology (699)

전화

415-231-5660

주소

151 Oyster Point Boulevard, Suite 300, South San Francisco

직원

65

트위터

다음 수익 날짜

2024-05-02

최신 SEC 제출 서류

ALEC's Discussions on Twitter

알렉터 Stock (ALEC) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-01-06	다운그레이드	BofA Securities	Buy → Neutral
2022-09-09	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2022-07-07	개시	Mizuho	Buy
2022-04-13	개시	Goldman	Sell
2022-03-08	다운그레이드	Stifel	Buy → Hold
2021-09-27	개시	William Blair	Outperform
2021-01-15	재개	BofA Securities	Buy
2020-06-24	개시	H.C. Wainwright	Buy
2020-04-28	개시	Goldman	Buy
2020-03-06	개시	Citigroup	Buy
2020-02-27	개시	Barclays	Overweight
2020-02-19	개시	Stifel	Buy
2019-11-21	개시	BTIG Research	Buy
2019-03-04	개시	Barclays	Overweight
2019-03-04	개시	BofA/Merrill	Buy
2019-03-04	개시	Morgan Stanley	Overweight
2019-03-04	개시	SVB Leerink	Outperform

모두보기

알렉터 주식(ALEC)의 최신 뉴스

Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know

Zacks Investment Research

Alector to Participate in Upcoming Healthcare Conferences

GlobeNewswire Inc.

Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call

GlobeNewswire Inc.

Earnings Preview: Alector (ALEC) Q4 Earnings Expected to Decline

Zacks Investment Research

Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease

GlobeNewswire Inc.

Strength Seen in Alector (ALEC): Can Its 6.0% Jump Turn into More Strength?

Zacks Investment Research

알렉터 (ALEC) 재무 분석

알렉터 (ALEC) 매출 2024

알렉터 (ALEC) 순이익 2024

알렉터 (ALEC) 현금흐름 2024

알렉터 (ALEC) 주당 순이익 2024